Design, synthesis and in vitro antiproliferative activity of new thiazolidinedione-1,3,4-oxadiazole hybrids as thymidylate synthase inhibitors

Thymidylate synthase (TS) has been an attention-grabbing area of research for the treatment of cancers due to their role in DNA biosynthesis. In the present study, we have synthesised a library of thiazolidinedione-1,3,4-oxadiazole hybrids as TS inhibitors. All the synthesised hybrids followed Lipin...

Full description

Bibliographic Details
Main Authors: Zohor Mohammad Mahdi Alzhrani, Mohammad Mahboob Alam, Thikryat Neamatallah, Syed Nazreen
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Online Access:http://dx.doi.org/10.1080/14756366.2020.1759581
id doaj-dde8a52c122b40dab2682605bcecf348
record_format Article
spelling doaj-dde8a52c122b40dab2682605bcecf3482021-07-15T13:10:32ZengTaylor & Francis GroupJournal of Enzyme Inhibition and Medicinal Chemistry1475-63661475-63742020-01-013511116112310.1080/14756366.2020.17595811759581Design, synthesis and in vitro antiproliferative activity of new thiazolidinedione-1,3,4-oxadiazole hybrids as thymidylate synthase inhibitorsZohor Mohammad Mahdi Alzhrani0Mohammad Mahboob Alam1Thikryat Neamatallah2Syed Nazreen3Department of Chemistry, Faculty of Science, Albaha UniversityDepartment of Chemistry, Faculty of Science, Albaha UniversityDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz UniversityDepartment of Chemistry, Faculty of Science, Albaha UniversityThymidylate synthase (TS) has been an attention-grabbing area of research for the treatment of cancers due to their role in DNA biosynthesis. In the present study, we have synthesised a library of thiazolidinedione-1,3,4-oxadiazole hybrids as TS inhibitors. All the synthesised hybrids followed Lipinski and Veber rules which indicated good drug likeness properties upon oral administration. Among the synthesised hybrids, compound 9 and 10 displayed 4.5 and 4.4 folds activity of 5-Fluorouracil, respectively against MCF-7 cell line whereas 3.1 and 2.5 folds cytotoxicity against HCT-116 cell line. Furthermore, compound 9 and 10 also inhibited TS enzyme with IC50 = 1.67 and 2.21 µM, respectively. Finally, the docking studies of 9 and 10 were found to be consistent with in vitro TS results. From these studies, compound 9 and 10 has the potential to be developed as TS inhibitors.http://dx.doi.org/10.1080/14756366.2020.17595812,4-thiazolidinediones1,3,4-oxadiazolesthymidylate synthasemolecular dockingpharmacokinetics
collection DOAJ
language English
format Article
sources DOAJ
author Zohor Mohammad Mahdi Alzhrani
Mohammad Mahboob Alam
Thikryat Neamatallah
Syed Nazreen
spellingShingle Zohor Mohammad Mahdi Alzhrani
Mohammad Mahboob Alam
Thikryat Neamatallah
Syed Nazreen
Design, synthesis and in vitro antiproliferative activity of new thiazolidinedione-1,3,4-oxadiazole hybrids as thymidylate synthase inhibitors
Journal of Enzyme Inhibition and Medicinal Chemistry
2,4-thiazolidinediones
1,3,4-oxadiazoles
thymidylate synthase
molecular docking
pharmacokinetics
author_facet Zohor Mohammad Mahdi Alzhrani
Mohammad Mahboob Alam
Thikryat Neamatallah
Syed Nazreen
author_sort Zohor Mohammad Mahdi Alzhrani
title Design, synthesis and in vitro antiproliferative activity of new thiazolidinedione-1,3,4-oxadiazole hybrids as thymidylate synthase inhibitors
title_short Design, synthesis and in vitro antiproliferative activity of new thiazolidinedione-1,3,4-oxadiazole hybrids as thymidylate synthase inhibitors
title_full Design, synthesis and in vitro antiproliferative activity of new thiazolidinedione-1,3,4-oxadiazole hybrids as thymidylate synthase inhibitors
title_fullStr Design, synthesis and in vitro antiproliferative activity of new thiazolidinedione-1,3,4-oxadiazole hybrids as thymidylate synthase inhibitors
title_full_unstemmed Design, synthesis and in vitro antiproliferative activity of new thiazolidinedione-1,3,4-oxadiazole hybrids as thymidylate synthase inhibitors
title_sort design, synthesis and in vitro antiproliferative activity of new thiazolidinedione-1,3,4-oxadiazole hybrids as thymidylate synthase inhibitors
publisher Taylor & Francis Group
series Journal of Enzyme Inhibition and Medicinal Chemistry
issn 1475-6366
1475-6374
publishDate 2020-01-01
description Thymidylate synthase (TS) has been an attention-grabbing area of research for the treatment of cancers due to their role in DNA biosynthesis. In the present study, we have synthesised a library of thiazolidinedione-1,3,4-oxadiazole hybrids as TS inhibitors. All the synthesised hybrids followed Lipinski and Veber rules which indicated good drug likeness properties upon oral administration. Among the synthesised hybrids, compound 9 and 10 displayed 4.5 and 4.4 folds activity of 5-Fluorouracil, respectively against MCF-7 cell line whereas 3.1 and 2.5 folds cytotoxicity against HCT-116 cell line. Furthermore, compound 9 and 10 also inhibited TS enzyme with IC50 = 1.67 and 2.21 µM, respectively. Finally, the docking studies of 9 and 10 were found to be consistent with in vitro TS results. From these studies, compound 9 and 10 has the potential to be developed as TS inhibitors.
topic 2,4-thiazolidinediones
1,3,4-oxadiazoles
thymidylate synthase
molecular docking
pharmacokinetics
url http://dx.doi.org/10.1080/14756366.2020.1759581
work_keys_str_mv AT zohormohammadmahdialzhrani designsynthesisandinvitroantiproliferativeactivityofnewthiazolidinedione134oxadiazolehybridsasthymidylatesynthaseinhibitors
AT mohammadmahboobalam designsynthesisandinvitroantiproliferativeactivityofnewthiazolidinedione134oxadiazolehybridsasthymidylatesynthaseinhibitors
AT thikryatneamatallah designsynthesisandinvitroantiproliferativeactivityofnewthiazolidinedione134oxadiazolehybridsasthymidylatesynthaseinhibitors
AT syednazreen designsynthesisandinvitroantiproliferativeactivityofnewthiazolidinedione134oxadiazolehybridsasthymidylatesynthaseinhibitors
_version_ 1721300975406284800